Vicarious Surgical (RBOT) Capital Expenditures (2020 - 2025)

Vicarious Surgical (RBOT) has 6 years of Capital Expenditures data on file, last reported at -$15000.0 in Q3 2025.

• On a quarterly basis, Capital Expenditures rose 54.55% year-over-year to -$15000.0 in Q3 2025; TTM through Sep 2025 was -$60000.0, a 105.87% decrease from a year earlier, with the FY2024 full-year figure at -$65000.0, down 103.89% from the prior year.
• Capital Expenditures for Q3 2025 stood at -$15000.0, down from $23000.0 in the prior quarter.
• Over the last five years, Capital Expenditures for RBOT reached as high as $2.0 million in Q1 2022 and fell as low as -$3.5 million in Q3 2022.
• Historically, Capital Expenditures has averaged $156631.6 across 5 years, with a median of $82000.0 in 2021.
• Across the five-year window, Capital Expenditures slumped 4414.63% in 2022 and surged 1896.15% in 2023, its largest moves.
• Year by year, Capital Expenditures stood at $867000.0 in 2021, then tumbled by 94.0% to $52000.0 in 2022, then jumped by 1896.15% to $1.0 million in 2023, then sank by 104.82% to -$50000.0 in 2024, then jumped by 70.0% to -$15000.0 in 2025.
• Per Business Quant data, the three most recent Capital Expenditures figures were -$15000.0 in Q3 2025, $23000.0 in Q2 2025, and -$18000.0 in Q1 2025.